AJANTPHARM / FY26 summary

The year in one view.

Ajanta Pharma · annual summary assembled from the available FY26 source records.

Research layer active

Revenue across quarters

14,310

₹ Cr where applicable

PAT across quarters

2,792

₹ Cr where applicable

Source quarters

12

₹ Cr where applicable

EBITDA (₹ Cr)PositiveWatchNegative
12 actual records
Actual quarterly EBITDA (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q1 FY24: 271 · Positive source sentiment · 2023-07-14Q1 FY24Q2 FY24: 291 · Positive source sentiment · 2023-11-10Q2 FY24Q3 FY24: 314 · Positive source sentiment · 2024-01-30Q3 FY24Q4 FY24: 278 · Positive source sentiment · 2024-05-14Q4 FY24Q1 FY25: 330 · Positive source sentiment · 2024-08-14Q1 FY25Q2 FY25: 311 · Positive source sentiment · 2024-11-12Q2 FY25Q3 FY25: 321 · Positive source sentiment · 2025-02-10Q3 FY25Q4 FY25: 297 · Positive source sentiment · 2025-05-15Q4 FY25Q1 FY26: 351 · Positive source sentiment · 2025-08-01Q1 FY26Q2 FY26: 328 · Positive source sentiment · 2025-11-07Q2 FY26Q3 FY26: 382 · Positive source sentiment · 2026-02-14Q3 FY26Q4 FY26: 333 · Positive source sentiment · 2026-05-15Q4 FY26382271
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.